Anaconda Pharma Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $45.7M

Anaconda Pharma General Information

Description

Developer of treatments for infections by human papillomavirus. The company is developing theraputics for the treatment of infections by human papillomavirus, condyloma and related diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Villejuif Bio Park
  • 1 mail du Professeur Georges Mathé
  • 94800 Villejuif
  • France
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Villejuif Bio Park
  • 1 mail du Professeur Georges Mathé
  • 94800 Villejuif
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anaconda Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 03-Jun-2015 $45.7M Completed Pre-Clinical Trials
2. Later Stage VC (Series B) 19-Jul-2010 Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Nov-2003 Completed Startup
To view Anaconda Pharma’s complete valuation and funding history, request access »

Anaconda Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of treatments for infections by human papillomavirus. The company is developing theraputics for the treatment
Biotechnology
Villejuif, France
7 As of 2012

Cambridge, MA
 

Thousand Oaks, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Anaconda Pharma Competitors (7)

One of Anaconda Pharma’s 7 competitors is Avalyn Pharma, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Avalyn Pharma Venture Capital-Backed Cambridge, MA
Amgen Formerly PE-Backed Thousand Oaks, CA
Ona Therapeutics Venture Capital-Backed Barcelona, Spain
Lung Therapeutics Formerly VC-backed Austin, TX
Cardurion Venture Capital-Backed Burlington, MA
You’re viewing 5 of 7 competitors. Get the full list »

Anaconda Pharma Patents

Anaconda Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3000490-A1 Process for synthesizing hydrazine useful in the treatment of papilloma virus Active 27-Dec-2012
US-9908858-B2 Method for the synthesis of a hydrazine that can be used in the treatment of the papilloma virus Active 27-Dec-2012
US-20150353517-A1 Method for the synthesis of a hydrazine that can be used in the treatment of the papilloma virus Active 27-Dec-2012
EP-2938595-B1 Method for the synthesis of a hydrazine that can be used in the treatment of the papilloma virus Inactive 27-Dec-2012
EP-2938595-A1 Method for the synthesis of a hydrazine that can be used in the treatment of the papilloma virus Active 27-Dec-2012 C07D295/135
To view Anaconda Pharma’s complete patent history, request access »

Anaconda Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anaconda Pharma Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aurinvest Venture Capital Minority
The Institut Pasteur Accelerator/Incubator Minority
To view Anaconda Pharma’s complete investors history, request access »

Anaconda Pharma FAQs

  • When was Anaconda Pharma founded?

    Anaconda Pharma was founded in 2003.

  • Where is Anaconda Pharma headquartered?

    Anaconda Pharma is headquartered in Villejuif, France.

  • What is the size of Anaconda Pharma?

    Anaconda Pharma has 7 total employees.

  • What industry is Anaconda Pharma in?

    Anaconda Pharma’s primary industry is Biotechnology.

  • Is Anaconda Pharma a private or public company?

    Anaconda Pharma is a Private company.

  • What is the current valuation of Anaconda Pharma?

    The current valuation of Anaconda Pharma is .

  • What is Anaconda Pharma’s current revenue?

    The current revenue for Anaconda Pharma is .

  • How much funding has Anaconda Pharma raised over time?

    Anaconda Pharma has raised $3.24M.

  • Who are Anaconda Pharma’s investors?

    Aurinvest and The Institut Pasteur have invested in Anaconda Pharma.

  • Who are Anaconda Pharma’s competitors?

    Avalyn Pharma, Amgen, Ona Therapeutics, Lung Therapeutics, and Cardurion are some of the 7 competitors of Anaconda Pharma.

  • When was Anaconda Pharma acquired?

    Anaconda Pharma was acquired on 03-Jun-2015.

  • Who acquired Anaconda Pharma?

    Anaconda Pharma was acquired by Aviragen Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »